Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Brinkmann

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Current Opinion in Immunology|August 17, 2002
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunityVolker Brinkmann, Kevin R Lynch
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Immunofluorescent Detection of NET Components in Paraffin-Embedded TissueUlrike Abu-Abed, Volker Brinkmann
Journal of Visualized Experiments : Jove|October 1, 2019
Immunofluorescence Labelling of Human and Murine Neutrophil Extracellular Traps in Paraffin-Embedded TissueUlrike Abu Abed, Volker Brinkmann
Expert Opinion on Investigational Drugs|February 17, 2007
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosisThomas Baumruker, Andreas Billich, Volker Brinkmann
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier functionVolker Brinkmann, Jason G Cyster, Timothy Hla
Methods in Cell Biology|July 12, 2008
Infection at the cellular levelChristian Goosmann, Ulrike Abu Abed, Volker Brinkmann
International Immunopharmacology|December 13, 2006
FTY720 preferentially depletes naive T cells from peripheral and lymphoid organsMatthias Hofmann, Volker Brinkmann, Hans-Günter Zerwes
Neurology|February 23, 2011
Impact of sphingosine 1-phosphate modulation on immune outcomesDaniel D Pinschewer, Volker Brinkmann, Doron Merkler
American Heart Journal|December 3, 2014
Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implicationsJohn Camm, Timothy Hla, Rajesh Bakshi, et al.
Infection and Immunity|July 24, 2004
Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathwayHesham M Al-Younes, Volker Brinkmann, Thomas F Meyer
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Current Opinion in Immunology|August 17, 2002
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunityVolker Brinkmann, Kevin R Lynch
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Immunofluorescent Detection of NET Components in Paraffin-Embedded TissueUlrike Abu-Abed, Volker Brinkmann
Journal of Visualized Experiments : Jove|October 1, 2019
Immunofluorescence Labelling of Human and Murine Neutrophil Extracellular Traps in Paraffin-Embedded TissueUlrike Abu Abed, Volker Brinkmann
Expert Opinion on Investigational Drugs|February 17, 2007
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosisThomas Baumruker, Andreas Billich, Volker Brinkmann
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier functionVolker Brinkmann, Jason G Cyster, Timothy Hla
Methods in Cell Biology|July 12, 2008
Infection at the cellular levelChristian Goosmann, Ulrike Abu Abed, Volker Brinkmann
International Immunopharmacology|December 13, 2006
FTY720 preferentially depletes naive T cells from peripheral and lymphoid organsMatthias Hofmann, Volker Brinkmann, Hans-Günter Zerwes
Neurology|February 23, 2011
Impact of sphingosine 1-phosphate modulation on immune outcomesDaniel D Pinschewer, Volker Brinkmann, Doron Merkler
American Heart Journal|December 3, 2014
Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implicationsJohn Camm, Timothy Hla, Rajesh Bakshi, et al.
Infection and Immunity|July 24, 2004
Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathwayHesham M Al-Younes, Volker Brinkmann, Thomas F Meyer
Pageof 18